Opportunity Radar

← Back to search

Grant

Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)

View on Grants.gov ↗ Sign in to save

Type
Grant
Notice type
G
Agency
National Institutes of Health
Sub-agency
HHS-NIH11
Solicitation #
PAR-25-362
Posted
Dec 30, 2024
Response due
Nov 5, 2028
Archive date
Dec 5, 2028
CFDA / Assistance listing
93.865
Award ceiling
$400,000
Contact
grantsinfo@nih.gov
Source
Grants.gov

Description

The purpose of this Notice of Funding Opportunity (NOFO) is tofurther elucidate the mechanisms of early immune development in utero, during the early post-natal period and during early childhood in neonates, infants, and children and adolescents with or without in-utero exposure to HIV or Anti-Retroviral Therapeutics (ART).This initiative aims to understand intricate mechanisms of immune cells at the maternal-fetal interface, T and B cell development and maturation in offspring, and local immune responses and the role of systemic immunity.

Similar open opportunities